SARS-CoV-2 Delta variant, SARS-CoV-2 lineage B.1.617

SARS-CoV-2 Delta variant, SARS-CoV-2 lineage B.1.617

AY.1, AY.1 variant, AY.2, AY.4.2, AY.4.2 Delta sublineage, AY1, AY2, AY4.2, AY 1, AY 2, B.1.617, B.1.617.2, B.1.617.2.1, B.1.617.2.1 variant, B.1.617 strain, B1.617, COVID-19 Delta, COVID-19 Delta variant, COVID-19 Kappa, COVID Delta, Delta+, Delta+ variant, Delta (SARS-CoV-2), Delta covid, Delta COVID, Delta Covid, Delta COVID-19, Delta plus, Delta Plus COVID variant, Delta plus variant, Delta strain, Delta variant, Delta variant of coronavirus, Delta variant of COVID-19, Double mutant, G/452R.V3, India variant, Indian COVID-19 strain, Indian COVID strain, Indian Variant, Indian variant COVID, Indian variant COVID-19, Johnson variant, Lineage AY.1, lineage B.1.617, lineage B.1.617.2, Lineage B.1617.1, Nepal variant, SARS-CoV-2 Delta plus variant, SARS-CoV-2 Delta Plus variant, SARS-CoV-2 delta variant, SARS-CoV-2 lineage B.1.617.2, Variant Delta, Δ variant

21A/S:478K, B.1.617, B.1.617.2, B.1.617.2.1, B.1.617 lineage, B.1.617 variant, COVID-19 B.1.617 variant, Delta, Delta variant, delta variant, G/452R.V3, Indian COVID-19 variant, Indian double mutant variant, Indian variant, lineage B.1.617, Lineage B.1.617.2, SARS-CoV-2 B.1.617 variant, Variant Under Investigation-21 April 01, Variant Under Investigation-21APR-01, VOC-21APR-02, VUI-21APR-01